Package(a):
VIAL: 1 x 5 ml (30 mg). Dosage(a):
135 mg/m² administered I.V. over 24 hours every 3 weeks. Prescribing Restrictions:
Package(b):
VIAL: 1 x 17 ml (100 mg). Dosage(b):
135 mg/m² administered I.V. over 24 hours every 3 weeks. Prescribing Restrictions: None
Package(c):
VIAL: 1 x 50 ml (300 mg). Dosage(c):
135 mg/m² administered I.V. over 24 hours every 3 weeks. Prescribing Restrictions: None
Indications:
Alone or in combination for advanced carcinoma of the ovary, metastatic breast cancer, non-small cell lung cancer, Kaposi carcinoma, node-positive breast cancer, advanced gastric carcinoma. Contra-Indications:
Sensitivity to paclitaxel or cremophor. Special Precautions:
See prescribing information for full details. Side Effects:
See prescribing information for full details. Drug Interactions:
Cisplatin, doxorubicin.